Retatrutide appears to be a new medication in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in research studies. By boosting these https://mariyaheavi010776.tinyblogging.com/tirzepatide-a-promising-new-treatment-for-obesity-79971057